International Journal of Gynecological Cancer

The Wayback Machine - https://web.archive.org./web/20210919204405/https://ijgc.bmj.com/

Intro Pullout Text Widget

Impact Factor: 3.437
Citescore: 4.0
All metrics >>

The International Journal of Gynecological Cancer (IJGC) is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. Its content is read by gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. IJGC emphasizes a multidisciplinary approach and includes original research, reviews, and video articles.

IJGC is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

IJGC is a Plan S compliant Transformative Journal.

EDITOR-IN-CHIEF
Pedro Ramirez, MD, University of Texas MD Anderson Cancer Center
Editorial Board

COVID-19: A Message from BMJ

Listen to the IJGC weekly podcast. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

Twitter Feed

IJGC @IJGConline

ATARI trial: To test if ATR inh +/- PARP inh has activity in patients with ARID1A ‘loss’ & ‘no loss’ clear cell ca & other relapsed gyncancer.
🔗 https://t.co/MXBngSzgvU
#PMID: 34518240
@pedroramirezMD @agz_eriksson @OncoAlert @ESGO_society @ENYGO_official @IGCSociety #rarecancer https://t.co/OPlnrXKH2g

View on Twitter

IJGC @IJGConline

NEXT zoom #IJGCclub!
☑️ConCerv: a prospective trial of conservative op for low-risk early cervical cancer, w/ Dr. Kathleen Schmeler.
📆Tue, Oct 12th, 8a CDT, 9p CET
@IGCSociety @ESGO_society @pedroramirezMD @agz_eriksson @OncoAlert @kmschmeler @RParejaGineOnco
#cervicalcancer https://t.co/dipmJeGLq6

View on Twitter

IJGC @IJGConline

Thanks for 92 attendees that joined #IJGCclub!
Special thanks to Dr. Christina Fotopoulou @CF_PC_OvCaGroup, giving an in-depth JC.
Thanks @pedroramirezMD @RParejaGineOnco @agz_eriksson
for leading⭐
Shout out to amazing @IJGCfellows @ESGO_society @IGCSociety for preparation! https://t.co/00r1xoSPjw

View on Twitter

IJGC @IJGConline

📅in 15 minutes!
Dr. Christina Fotopoulou invites YOU join Zoom Journal club
☑️ESGO #guideline for peri-op mgmt of #ovariancancer
➡️ https://t.co/bROgiOqzYq
@CF_PC_OvCaGroup @pedroramirezMD @agz_eriksson @OncoAlert @ESGO_society @ENYGO_official @IGCSociety #IJGCclub

View on Twitter

IJGC @IJGConline

Proud of our current & previous @IJGCfellows 🤩 and all their great work & achievements in #socialmedia & beyond! #FutureLeaders #GynOnc #GynCancer @bmj_latest @IGCSociety @ESGO_society @pedroramirezMD @agz_eriksson #medtwitter #Scientists4Future #GlobalCitizen @HsuMd https://t.co/0zI6uXzguV

View on Twitter

IJGC Fellows @IJGCfellows
To all our 1500 followers, we say thank you! It is always exciting as @IJGCfellows to be sharing the work of @IJGConline and connecting with colleagues around the world! @pedroramirezMD https://t.co/GUa4caGHuN

Authors

The International Journal of Gynecological Cancer accepts submissions of original research and reviews.

The Author Information section provides specific article requirements to help you turn your research into an article suitable for IJGC.

Information is also provided on editorial policy, Open Access fees and formatting.

Author information

Submit a paper

IJGC Zoom Journal Club

Current Time 0:00

Duration Time 0:00

Loaded: 0%

Progress: 0%

Stream TypeLIVE

Remaining Time -0:00

IJGC Journal Club, August 2021

13 August, 2021

Join Editor-in-Chief Pedro Ramirez, Social Media Editor Ane Gerda Zahl Eriksson, and the IJGC Editorial Fellows in a lively and entertaining discussion over Zoom of the lead article in IJGC's August 2021 issue (linkRecorded on the 10th of August 2021

Announcing New Editorial Board Member

We are very proud to announce a new member of the Editorial Board Member, Dr. Ainhoa Madariaga. Dr. Madariaga is a medical oncologist at 12 de Octubre Hospital in Madrid, Spain. Her clinical and academic areas of interest are gynecologic cancers, drug development and patient-reported outcome assessment.

Aug	SEP	Oct
	19
2020	2021	2022